Flying in the age of coronavirus comes packed with uncertainty about the health status of fellow travelers. Now, Florida's Tampa International Airport is running a pilot program that offers on-the-spot COVID-19 tests for travelers.

With more than 120 people participating in the optional testing per day, Joe Lopano, Tampa International Airport CEO, said the program is showing promising results.

"We've had some customers who have tested positive and Baycare, the healthcare professionals, have a discussion with that passenger and tell them that they should not continue on their way and passengers have accepted it," Lopano told Cheddar.

The airport offers two tests, the $125 PCR nasal swab, which usually takes 3 to 4 days to yield results, and the $50 rapid Antigen test. The cost of both tests, Lopano said, can be covered by insurance companies if travelers provide a receipt from the airport.

Testing at the airport, according to Lopano, will not have much impact on overall travel time. In fact, those not checking a bag only need to account for an additional 30 minutes as a cushion, he added. 

"It's immediate testing. Sometimes you have to wait in a short line. You'll get your results in 15 minutes, so it really is not a very time-consuming function and it's very convenient," Lopano said.

While other airports have implemented testing for specific destinations, Lopano said Tampa is the first to offer widespread testing for passengers on all flights arriving and departing. The pilot program is likely to continue running through the holiday season as the number of participants and customer satisfaction is assessed.

For Lopano, offering a testing site at the airport is not only maintaining passenger safety but can also help revitalize a struggling travel industry that is fighting to get customers off the ground.

"It's a high priority because we need to do whatever we can to create confidence in the travel experience and now that widespread testing is available, the technology is available, what better way to do that than right at the airport," he said.

Share:
More In Business
Cresco Labs to Become the Largest U.S. Cannabis Company by Sales With Columbia Care Acquisition
Cannabis producer Cresco Labs is acquiring rival Columbia Care in a $2 billion all-stock deal, creating the largest U.S. cannabis company by sales. The deal, which is expected to close in the fourth quarter of 2022, is one of the biggest in the industry's history and would make Cresco the dominant player in a market projected to reach $46 billion in revenue by 2026. Charlie Bachtell, CEO of Cresco Labs, joins Cheddar News' Closing Bell to discuss.
Sports Betting Brands Scaling Back Ads As Stocks Stumble
Sports betting has boomed over the past year; but at the same time, sports betting stocks have not been so hot. Now, some sports betting brands are starting to rethink how to spend their money, especially when it comes to ads. It will come after online sports betting brands spent more than $320 million on advertising in 2021, up 38% from 2020, per MediaRadar. Brendan Coffey, sports finance reporter for Sportico, joins Cheddar News' Closing Bell to discuss.
Rowing Machine Maker Hydrow Raises $55 Million
Rowing-machine maker, Hydrow, raised $55 million in Series D funding round, led by Constitution Capital. Hyrdow offers a connected rowing machine that costs $2,495. The company's funding round comes as the at-home fitness industry is facing some challenges, due to many consumers returning to gyms after working out at home during the pandemic. Bruce Smith, founder & CEO of Hydrow, joined Cheddar News' Closing Bell to discuss.
Investigators Probe Cause of China Plane Crash
Aviation expert Sally Gethin joined Cheddar News' Closing Bell to discuss the latest on the crash of a Boeing 737-800 NG in China, as investigators look for a reason for the sudden nosedive, and search for any sign of the 132 passengers onboard.
Load More